Explore By Subject Area   
Return Home
Register Here Menu

PODD: Partnerships in Drug Delivery

Date: Oct 28, 2024 - Oct 29, 2024

Location: Boston, MA

Day 1: Monday, October 28, 2024
Showing Events in 1 Track from 07:50am to 08:35am
Morning General Session Grand Ballroom Foyer
7:50AM - 8:35AM
Registration
Hosted By:
Showing Events in 1 Track from 08:35am to 09:05am
Annual Keynote Grand Ballroom, Concourse Level
8:35AM - 9:05AM
Annual Keynote with MIT’s Dr Robert Langer
Keynote:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
Moderated By:
Richard Tillyer, PhD, Global Head of Discovery, Product Development and Supply, Johnson & Johnson
Showing Events in 1 Track from 09:05am to 10:15am
Morning General Session Grand Ballroom, Concourse Level
9:05AM - 9:15AM
Co-Chairs' Opening Remarks
Co-Chairs:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca
Aly Jackson, MS, MBA, Business Development, Genentech / Roche
9:15AM - 9:30AM
Genentech / Roche Industry Overview on the Drug Delivery Landscape 2024
Speakers:
Aly Jackson, MS, MBA, Business Development, Genentech / Roche
9:30AM - 10:00AM
Ex-Liver Delivery of RNA/DNA to Facilitate In Vivo Gene Editing and In Vivo CAR T
Moderated By:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Panelists:
Mandana Borna, PhD, Associate Director, Head of Oligonucleotide Drug Product Development, Biogen
Alexander Curreri, PhD, Senior Scientist, Discovery Pharmaceutical Sciences, Merck
Shawn Davis, PhD, CEO, Liberate Bio
Jonathan Nolasco, Senior Scientist, Non-Viral Delivery, Novo Nordisk
10:00AM - 10:15AM
The Powers and Perils of Platforms
Speaker:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Showing Events in 1 Track from 10:15am to 11:05am
Morning Networking Break & Partnering
10:15AM - 11:05AM
PODD Grand Opening Networking Break & Partnering
Showing Events in 1 Track from 11:05am to 12:40pm
Morning General Session Continues Grand Ballroom, Concourse Level
11:05AM - 11:30AM
Zeitgeist Presentation: Re-Emergence of Drug Delivery Facilitated by the Disruption Effects of GLP-1 Drugs and Nucleic Acid Modalities
Zeitgeist:
Anand Subramony, PhD, Vice President, Drug Delivery, Device, Connected Solutions & Innovation, Eli Lilly and Company
11:30AM - 11:45AM
High Drug Load Formulations for Small and Large Molecules
Speaker:
Christopher Worrall, PhD, VP, US Business Development, Nanoform
11:45AM - 12:25PM
Pharma Company Spotlights
Speakers:
Stephen Buckley, PhD, VP, Advanced Drug Delivery, Novo Nordisk
Christoph Marschall, PhD, Head of Laboratory, Boehringer Ingelheim
Christopher Rodricks, MBA, Senior Director, Strategic Partnerships, Pfizer Ignite, Business Innovation Office, Pfizer
Harshal Shah, MBA, Head of Device Strategy & Innovation, Global Device and Packaging Unit (GDPU), Sanofi
Jill Steinbach-Rankins, PhD, Senior Associate Director, Innovation Technology, Boehringer Ingelheim
12:25PM - 12:40PM
Feasibility Assessments: Partnering Early to Mitigate Combination Product Development Risks and Improve Speed to Market
Speakers:
Peter Skutnik, Business Director, Wearables, BD Medical-Pharmaceutical Systems
Showing Events in 1 Track from 12:40pm to 01:40pm
Luncheon & Partnering Meetings
12:40PM - 1:40PM
Luncheon & Partnering Meetings
Showing Events in 1 Track from 01:40pm to 06:30pm
The Annual PODD Drug Delivery Technology Presentations in Ten Tracks
1:40PM - 6:30PM
The Annual PODD Drug Delivery Technology Presentations in Ten Tracks
Showing Events in 5 Tracks from 01:45pm to 04:00pm
Track 1A: Injectable Formulations & Technologies Grand Ballroom A, Concourse Level
Chaired by:
F. Javier Muñoz, PhD, MBA, Technology Evaluation Leader, F Hoffmann-La Roche
1:45PM - 2:00PM
SynBiosys ® LAI Microspheres and In Situ Forming Depots for Delivery of Peptides and Biologics
Speakers:
Rob Steendam, PhD, Chief Technology Officer, InnoCore Pharmaceuticals
2:00PM - 2:15PM
PharmaShell® Technology Enabling Long Acting GLP-1 Products
Speaker:
David Westberg, CEO, Nanexa
2:15PM - 2:30PM
Supplier Partner Proactivity to Support the Development of Reliable Combination Product Delivery Systems
Speaker:
Sylvain Stamper, R&D System Integration Leader, BD
2:30PM - 2:45PM
Chroniject Technology: A Solution to Long Acting Injectable Formulation and Scale-Up Challenges
Speakers:
Colin Spencer, Head of Technology Transfer, Project Manager, Oakwood Labs
2:45PM - 3:00PM
Dynamic Symbiosis of Drug Solubility, Microstructure and Polymer Chemistry in PLGA Microspheres
Speaker:
Andrew Clark, PhD, Director of Pharmaceutical Science, DigiM Solution
3:00PM - 3:15PM
Surf SnapShot™ Technology: An Injection in Seconds Instead of an Infusion in Hours
Speaker:
Bryan Mazlish, CEO, Surf Bio
3:15PM - 3:30PM
PURASORB®: Bioresorbable Polymers for Long-Acting Injectables: Past, Present, and Future
Speaker:
Morgan Fox, MSE, Senior Manager, Sales, Corbion
3:30PM - 3:45PM
BEPO® Technology : Flexible Design to Address Challenging Needs
Speaker:
Christophe Roberge, PhD, Partnering Director, MedinCell
3:45PM - 3:52PM
AI-Driven Automation for LAI Discovery and Scale-Up – A Case Study
Speaker:
Karthik Raman, PhD, CEO, Persist AI
3:52PM - 4:00PM
Oncolize: Treating Tumors from the Inside
Speaker:
Mike G.W. de Leeuw, Founder & CEO, OncoLize
Track 2A: Novel Devices: Self-Injectables, Wearables & Connected Devices Grand Ballroom B, Concourse Level
Chaired by:
Kinsuk Shah, M.Sc and MBA, SR AD, Combination Product Steward, Boehringer Ingelheim
1:45PM - 2:00PM
Meet SHL Medical’s Elexy™: Versatile. Reusable. Connected
Speaker:
Vince Masciopinto, Customer Solutions Director, SHL Medical
2:00PM - 2:15PM
Case Study: Proving the Gas-Powered AltaVISC Significantly Expands Delivery Window for High Viscosity / High-Volume Drugs
Speaker:
Nelson Quintana, Director, Drug Delivery Programs, Altaviz
2:15PM - 2:30PM
Navigating Trade-offs in Re-usable Injector Design: Balancing Sustainability, Cost, and Patient Outcomes
Speaker:
Steve Gowers, Head of Drug Delivery & Digital Health, TTP
2:30PM - 2:45PM
Vertical Integration Strategies that Propel Drug Delivery Systems to Market
Speaker:
Greg Panebianco, Sr. Director of Engineering & Customer Success, Flex
2:45PM - 3:00PM
Device Design and Container Challenges in Complex Formulations
Speaker:
Uri Baruch, Vice President and General Manager, SMC Ltd
3:00PM - 3:15PM
Targeted Drug Delivery: a Journey to Precise, Repeatable and Personalized Drug Delivery
Speaker:
John Burke, Managing Consultant, Team Consulting
3:15PM - 3:30PM
Industry Partnering for Successful Combination Products
Speaker:
Philipp Richard, MBA, Account & Business Development Manager, Ypsomed
3:30PM - 3:45PM
Connected Health – Is the Near-Term Opportunity in Clinical Development?
Speaker:
Andrew Dundon, Director Drug Delivery Systems Strategy, Jabil Pharma Delivery Solutions
3:45PM - 4:00PM
Considerations for Building a Low-Risk, Highly Scalable Supply Chain for Drug-Device Combination Products
Speaker:
Bill Welch, Executive Director Market Development, PCI Pharma Services
Track 3A: Oral, Mucosal, Transdermal & Other Non-Injectable Technologies Grand Ballroom D/E, Concourse Level
Chaired by:
Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals
1:45PM - 2:00PM
Exploring the Potential of Intranasal Delivery: The Next Era
Speaker:
Reenal Gandhi, Director, Business Development, Aptar Pharma
2:00PM - 2:15PM
Development and Pharmacoscintigraphic Analysis of Novel Dual-pulse Fixed Dose Combination Tablet
Speaker:
Darren Quinn, MChem, Head of Business Development, BDD Pharma
2:15PM - 2:30PM
Right from the Start: A Rapid Approach to Flexible and Scalable Drug Product
Speaker:
Jaspreet Arora, PhD, Director of Business Development, Serán Bioscience
2:30PM - 2:45PM
Solving the Insoluble: Disrupting Product Opportunities with Zerion’s Dispersome® Technology
Speaker:
Korbinian Löbmann, CSO & Co-Founder, Zerion Pharma A/S
2:45PM - 3:00PM
OzmoCAP®, a New Osmotic, Controlled Release Capsule
Speaker:
Kenneth Waterman, PhD, President, FreeThink Technologies, Inc.
3:00PM - 3:15PM
Sprinkle on Soft Food Formulations: An Easy-to-Swallow Dosage Format with Dose Flexibility
Speaker:
Srinivasan Shanmugam, PhD, Executive Director, Pharmaceutical Sciences, Adare Pharma Solutions
3:15PM - 3:30PM
Gastro-Retentive Drug Delivery Via Novel 3D Printed Tablets
Speakers:
Timothy Tracy, PhD, Senior Advisor, Triastek
3:30PM - 3:45PM
Solving Drug Delivery Challenges with Ingestible Drug-Device Combinations
Speaker:
Adi Mohanty, MBA, CEO, Biora Therapeutics, Inc.
3:45PM - 3:52PM
Revolutionizing Antiviral Treatments: Phase II Ready Orally Available Nanomedicines that Can Deliver Difficult APIs and Improve PK
Speaker:
Anil Diwan, PhD, President & Executive Chairman, Nanoviricides
3:52PM - 4:00PM
A Multi-Day Gastroretentive Drug Delivery Platform for Sustained Release of Small Molecules and Peptides
Speaker:
Camilla Easter, BVMedSci BVM BVS MRCVS, CEO, Oxford Medical Products
Track 4A: Cell & Gene Delivery Marina Ballroom I/II, Lobby Level
Chaired by:
Alireza Nomani, PhD, PharmD, Principal Scientist, Regeneron Pharmaceuticals
1:45PM - 2:00PM
Navigating the Last Mile: Best Practices for Successful Delivery Device Development for Advanced Therapies
Speaker:
Nathan Blazei, Senior Director, Strategic Solutions, Kymanox
2:00PM - 2:15PM
COATSOME® SS Series:Highly Versatile Ionizable Lipid as Vital Component of Lipid Nanoparticle for Gene Therapy and Vaccine Application
Speaker:
Kasumi Ito, Research scientist, NOF CORPORATION
2:15PM - 2:30PM
Precision Drug Delivery: Customized Cell Encapsulation, Hydrogels and Microbeads to Target Therapeutics Exactly Where They’re Needed
Speaker:
Dr. Stella Vnook, CEO, Likarda
2:30PM - 2:45PM
Delivering on the Promise of Genetic Medicines: Safe and Effective In Vivo Delivery of Nucleic Acids with the Fusogenix PLV Platform
Speaker:
John Lewis, PhD, CEO, Entos Pharmaceuticals
2:45PM - 3:00PM
SAIL Biomedicines – Generating Tomorrow’s Medicines Today
Speaker:
Kerry Benenato, PhD, Chief Platform Officer, Sail Biomedicines
3:00PM - 3:15PM
SORT LNP Platform for Hepatic and Extrahepatic Delivery
Speaker:
Ariel Kantor, PhD, SVP, Head of Business & Corporate Development, ReCode
3:15PM - 3:30PM
Novel Ultrasound Guided Non-Viral Gene Therapy Platform Allows Targeting of Almost any Organ
Speaker:
Shawn Fu, MD, Vice President of CorpDev and Head of Strategy, SonoThera
3:30PM - 3:45PM
Design and Optimization of a Peptoid-Based Platform for Therapeutic mRNA Delivery
Speaker:
Colin McKinlay, PhD, Senior Director, Chemistry and Delivery Technologies, Nutcracker
3:45PM - 3:52PM
A Simple, Safe, Affordable and Scalable Intracellular Delivery Platform for “Naked” RNA/DNA Vaccines and Therapeutics
Speaker:
Gaurav Byagathvalli, CEO, Piezo
3:52PM - 4:00PM
Making Oligonucleotides Better Medicines with Bottlebrush Polymers
Speaker:
Carl LeBel, PhD, CEO, pacDNA
Track 5A: Excipient Innovation Marina Ballroom III/IV, Lobby Level
Chaired by:
Stephen Spagnol, PhD, Director, Business Development & Licensing, Merck
1:45PM - 2:00PM
Targeted Delivery of Microbiome: A Case Study on Development of Functional Coated Capsules Leading to Clinical Trial
Speaker:
Mohammed Irfan Syed, PhD, Associate Director, Formulation & Application Services, Evonik
2:00PM - 2:15PM
mPredict™ Co-crystal Prediction Service: An Introduction to faster co-crystal screening
Speakers:
Mitali Bhagwat, M.Pharm, Strategic Product manager, MilliporeSigma
2:15PM - 2:30PM
Utilizing Poly(2-oxazoline) Triblock Copolymers to Increase Solubility, Bioavailability and Anti-tumor Activity of Poorly Soluble Drugs In Vivo
Speaker:
Bruce Frank, PhD, President and Chief Scientific Officer, DelAQUA Pharmaceuticals, Inc.
2:30PM - 2:45PM
Does the Purity of Dimethyl Sulfoxide Affect Cell viability?
Speaker:
Nigel Langley, PhD, MBA, FRSC, Global Technical Director Life Sciences, Gaylord Chemical
2:45PM - 3:00PM
Phospholipid Excipients, Existing Usages and Key Advantages
Speaker:
Alexander Aydt, PhD, Senior Manager, Lipoid LLC
3:00PM - 3:15PM
Hydralese®: A Tunable Polymer Platform for Long-Acting Drug Delivery
Speaker:
Manasi Baker, PhD, Senior Scientist, Secant Group
3:15PM - 3:30PM
API Carrier: Hyaluronic Acid Nanogel (Sonanos™) for Sustained Release and Solubility Enhancement
Speaker:
Yoshiyuki Nakagawa, PhD, Assistant Manager, Asahi Kasei Corporation
3:30PM - 3:37PM
Dramatic Oncolytic Virus Transduction Through Targeted and Protected Intravenous Administration
Speaker:
Clay Larsen, President and CEO, Vesselon, Inc.
3:37PM - 3:45PM
Biotts’ MTC-Y Technology: Revolutionizing Diabetology with Needle-Free, Non-Invasive Transdermal Insulin Delivery
Speaker:
Pawel Biernat, PhD, Co-founder and Patent Co-author, Biotts
Showing Events in 1 Track from 04:00pm to 04:25pm
Networking Break
4:00PM - 4:25PM
25-Minute Ice Cream and Networking Break
Showing Events in 5 Tracks from 04:30pm to 06:30pm
Track 1B: Injectable Formulations & Technologies Grand Ballroom A, Concourse Level
Chaired by:
Srini Sridharan, PhD, Executive Director, Drug Delivery & Product Integration, Bristol-Myers Squibb
4:30PM - 4:45PM
Challenge Accepted: TheraPEA Innovation for Long Acting Formulations of Biologics
Speaker:
George Mihov, PhD, Principal Scientist - Drug Delivery Solutions, dsm-firmenich
4:45PM - 5:00PM
New Containment Solutions to Mitigate Risk for Gene Therapies
Speaker:
Vidya Murthy, PhD, Director, Scientific Communication, Advanced Therapies, West Pharmaceutical Services
5:00PM - 5:15PM
Revolutionizing Drug & Vaccine Delivery with Blow Fill Seal
Speaker:
Joseph (Joe) Wojcik, MBA, PMP, Senior Director, Pharmaceutical Development Services, ApiJect
5:15PM - 5:30PM
Avoid Injectables Pitfalls: 5 Early Considerations to Shorten Timelines and Reduce Costs Throughout Your Program
Speaker:
Ryan Swanson, PhD, Director of Process Development, Lifecore Biomedical, LLC
5:30PM - 5:45PM
Innovative Dual Chamber Blow Fill Seal (BFS) Injection System Development: A Collaborative Case Study by ApiJect and PSN Labs
Speakers:
Mark Burchnall, Engineering Director, PSN Labs
Molly Weaver, PhD, Chief Operating Officer, ApiJect
5:45PM - 6:00PM
The Nanoprimer: A Significant Opportunity to Boost the Efficacy of Nanomedicine
Speaker:
Matthieu Germain, Dr, Senior Director, Head of Curadigm Platform, Nanobiotix
6:00PM - 6:15PM
MAGiGSPHERE, High-Drug Loaded Microspheres for Long-Acting Injectables
Speaker:
Heeyong Lee, PhD, CEO, G2GBio
6:15PM - 6:22PM
Ultrasound-Mediated Drug Delivery for Enhanced Cancer Therapy and Tumor Microenvironment Modulation
Speaker:
Chung-Hsin Wang, PhD, Founder, Trust Bio-sonics Inc.
6:22PM - 6:30PM
Early Clinical Efficacy Results of SonoTran Presentation in mCRC Patients: A Game-Changing Ultrasound-Triggered Drug Delivery Solution
Speaker:
Jérôme Marzinski, MBA, CEO, OxSonics
Track 2B: Novel Device Technologies Grand Ballroom B, Concourse Level
Chaired by:
Dominick DeGrazio, Early Project Engineering Lead, Early Engagement and Deviceability, GSK
4:30PM - 4:45PM
Innovating for Pediatric Access to Address Unmet and Emerging Drug Delivery Needs in Applications Involving Variable Dosing
Speaker:
Gautam Shetty, PhD, Founder, CEO, Congruence Medical
4:45PM - 5:00PM
3 Essential Rules of Mechanical Design in a Connected World
Speaker:
Jon Powell, Head of Manufacturing, Cambridge Design Partnership
Linda Tharby, President and CEO, Koru Medical
5:00PM - 5:15PM
The Emerging Role of Nanoparticle Delivery Platform Technologies in the Translation of Genetic Medicines
Speaker:
Anthony Duong, PhD, Lead Drug Delivery Scientist, Battelle
5:15PM - 5:30PM
The Reality of the Large Volume Subcutaneous Device Landscape: How to Stick the Landing of Commercialization
Speaker:
Adam Edelhauser, Director of R&D, KORU Medical Systems
5:30PM - 5:45PM
Breakthroughs in Micro Molding for Drug Delivery – Unlocking New Frontiers
Speaker:
Brent Hahn, MBA, SVP, Isometric Micro Molding
5:45PM - 6:00PM
Ampoule Filled Syringe: The PFS Alternative that Delivers Superior Shelf Life While Reducing Years of Development and Manufacturing Time
Speaker:
Eric Sugalski, Founder & CEO, Archimedic
6:00PM - 6:15PM
Joint Exploration Project: Pre-Filled Syringe Enabling Intradermal Delivery
Speaker:
Uli Kuchenbrod, MBA, Director Product Development & Design, Vetter Pharma-Fertigung GmbH & Co KG
6:15PM - 6:22PM
Software Modulated Wearable Subcutaneous Delivery for Patient Acceptance and Time/Cost to Market
Speaker:
David Johnston, Chief Product Officer, Torramics
6:22PM - 6:30PM
A Novel Subcutaneous & Intra-Muscular Closed System Transfer Device
Speaker:
William Wijnberg, COO, Zephyrus Innovations
Track 3B: Novel Injectable and Non-Injectable Technologies Grand Ballroom D/E, Concourse Level
Chaired by:
Abhijeet Maurya, PhD, Principal Scientist, Amgen
4:30PM - 4:45PM
Disaccharides: Simple Raw Materials or a Hidden Weakness in the Biopharmaceutical Supply Chain?
Speaker:
Ross Blezard, Global technical lead: Biopharma and Inhalation, DFE Pharma
4:45PM - 5:00PM
Creating Next Generation Therapies with Drug-Eluting Implants
Speaker:
Tom Quinci, Global Leader for External Innovation and Partnerships, Celanese
5:00PM - 5:15PM
Nanomedicine Development and Manufacturing with DELOS Nanovesicle Technology
Speaker:
Alba Cordoba, PhD, Tech Transfer & Business Development Director, Nanomol Technologies
5:15PM - 5:30PM
Fill and Finish for Reconstituted Product Devices
Speaker:
Joan Melé, Chief Commercial Officer, Dara
5:30PM - 5:45PM
Spray Drying to Overcome Cold Storage of RNA-Loaded Lipid Nanoparticles
Speaker:
Mark Kastantin, PhD, VP of Manufacturing Technology, Serán Bioscience
5:45PM - 6:00PM
Eliminating silos in the Drug Delivery Value Chain: A Case Study From Grand River Aseptic Manufacturing and LTS Lohmann Device Technologies
Speaker:
Mary Lou Glotzbach, Business Development Executive, Grand River Aseptic Manufacturing
Greg Moakes, PhD, MBA, Executive Vice President, Business Development, Sorrel Platform, LTS Lohmann Therapie-Systeme AG, LTS Device Technologies
6:00PM - 6:15PM
Cutting-Edge Liposomal Nano-Drug Delivery: Clinical Breakthroughs in Oncology and Neurology
Speaker:
Stéfan Halbherr, PhD, CEO / Country Manager, InnoMedica Switzerland AG
6:15PM - 6:22PM
Unlocking Vaginal Drug Delivery Opportunities with Callavid®
Speaker:
Andrew Lewis, PhD, Principal Scientist, Calla Lily Clinical Care
6:22PM - 6:30PM
Enabling Transdermal Delivery of Large Molecules and Combination Therapies
Speaker:
Jake Lombardo, CEO & Co-founder, Anodyne
Track 4B: Cell, Gene & Novel Biologics Delivery Marina Ballroom I/II, Lobby Level
Chaired by:
Samantha Sarett, PhD, Senior Director, Nanomedicines, Eli Lilly and Company
4:30PM - 4:45PM
​​Non-Lipid Polymer-Based Nanoparticles - Unlocking Gene Therapy Delivery Potential
Speaker:
Shira Orr, PhD, CEO, Envoya
4:45PM - 5:00PM
Size Controllable LNP Fabrication Plays a Crucial Role in Advancing LNPs Towards the Clinic
Speaker:
Matt Freeman, PhD, Senior Scientist, Phosphorex
5:00PM - 5:15PM
The Sustained Release of Biologics, Large and Small Molecules with Novel Photo Crosslinked Biodegradable Technologies
Speaker:
Patrick Ruane, PhD, Chief Operating Officer, Re-Vana Therapeutics
5:15PM - 5:30PM
Crossing Barriers: Pioneering Intracellular Delivery in Biologic Therapies
Speaker:
Tal Sines, PhD, VP of Business Development, Biond Biologics
5:30PM - 5:45PM
yEVs for delivery of Proteins, Nucleic Acids and Small-Molecule Drugs
Speakers:
Bruce McCormick, CEO, Mercury Bio
5:45PM - 6:00PM
MINC: A Revolutionary Brain Delivery Platform for Biologics
Speaker:
Pauline Lau, PhD, CEO, Suntec Medical, Inc.
6:00PM - 6:15PM
Lipid Nanoparticles – Carriers for Biologics and Nucleic Acids Delivery
Speaker:
Shaukat Ali, PhD, Senior Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
6:15PM - 6:22PM
Turning Implantable Devices into Therapeutic Treatments: Ushering in the Next Evolution in Targeted Therapies
Speaker:
Luis Alvarez, PhD, Founder & CEO, Theradaptive
6:22PM - 6:30PM
Enabling Gene-Length DNA Insertions with Single-Stranded DNA Templates Adaptable to Non-Viral Delivery Modalities
Speaker:
Floris Engelhardt, PhD, CEO/CSO, Kano Therapeutics
Track 5B: Self-Injection Devices, Syringes, Primary Container & Packaging Solutions Marina Ballroom III/IV, Lobby Level
Chaired by:
Theresa Scheuble, Head, Enterprise Design & Innovation, Johnson and Johnson
4:30PM - 4:45PM
Solutions for Emerging Challenges in Injectable Drug Delivery
Speaker:
Laxman Halleppanavar, Head of Portfolio Strategy and Management, Credence MedSystems, Inc.
4:45PM - 5:00PM
Titration Dosing with Auto-Injectors: The Critical Importance of Device Selection
Speaker:
Rob Schulz, RAC, Senior Vice President, Suttons Creek
5:00PM - 5:15PM
Integrating Primary container solutions with CDMO capabilities for Biotech parenteral drugs
Speaker:
Michele Guasti, Global Product Manager at the Pharmaceutical Solutions Division, Terumo
5:15PM - 5:30PM
Digital Drug Delivery
Speaker:
Patrick Anquetil, PhD, MBA, CEO, Portal Instruments
5:30PM - 5:45PM
Meeting GLP-1 Market Needs: Your One-Stop Solution for Comprehensive Auto-Injector and Pen Injector Systems
Speakers:
Tommaso Borghi, PhD, Director of Product Development of Drug Delivery Systems, Stevanato Group
5:45PM - 6:00PM
Vaccine Wastage Reduction With Newly Developed Blow/Fill/Seal Packaging
Speaker:
Tim Kram, Managing Director, Rommelag USA
6:00PM - 6:15PM
Sterile Product Introduction and Tech Transfers in a Crowded Market
Speaker:
Kimberly Brown, Director, Client Portfolio & Relationship Management, Kindeva
6:15PM - 6:22PM
Dual Chamber, Wearable, Subcutaneous Delivery Device
Speaker:
Kevin Schmid, Chief Operating Officer, Modular Medical
6:22PM - 6:30PM
Pharma Latch: Intradermal is Now a Realistic & Exciting Route of Administration
Speakers:
Adam Rock, Strategic Partnerships and Commercialisation Manager, Pharma Latch
Showing Events in 1 Track from 06:30pm to 07:30pm
PODD Networking Reception & Partnering Meetings
6:30PM - 7:30PM
PODD Networking Reception & Partnering Meetings
Hosted By:
Showing Events in 1 Track from 07:30pm to 07:35pm
Day One Concludes
7:30PM - 7:35PM
Day One Concludes
Showing Events in 1 Track from 07:50am to 08:35am
Morning General Session
Grand Ballroom Foyer
7:50AM - 8:35AM
Registration
Hosted By:
Showing Events in 1 Track from 08:35am to 09:05am
Annual Keynote
Grand Ballroom, Concourse Level
8:35AM - 9:05AM
Annual Keynote with MIT’s Dr Robert Langer
Keynote:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
Moderated By:
Richard Tillyer, PhD, Global Head of Discovery, Product Development and Supply, Johnson & Johnson
Showing Events in 1 Track from 09:05am to 10:15am
Morning General Session
Grand Ballroom, Concourse Level
9:05AM - 9:15AM
Co-Chairs' Opening Remarks
Co-Chairs:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca
Aly Jackson, MS, MBA, Business Development, Genentech / Roche
9:15AM - 9:30AM
Genentech / Roche Industry Overview on the Drug Delivery Landscape 2024
Speakers:
Aly Jackson, MS, MBA, Business Development, Genentech / Roche
9:30AM - 10:00AM
Ex-Liver Delivery of RNA/DNA to Facilitate In Vivo Gene Editing and In Vivo CAR T
Moderated By:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Panelists:
Mandana Borna, PhD, Associate Director, Head of Oligonucleotide Drug Product Development, Biogen
Alexander Curreri, PhD, Senior Scientist, Discovery Pharmaceutical Sciences, Merck
Shawn Davis, PhD, CEO, Liberate Bio
Jonathan Nolasco, Senior Scientist, Non-Viral Delivery, Novo Nordisk
10:00AM - 10:15AM
The Powers and Perils of Platforms
Speaker:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Showing Events in 1 Track from 10:15am to 11:05am
Morning Networking Break & Partnering
10:15AM - 11:05AM
PODD Grand Opening Networking Break & Partnering
Showing Events in 1 Track from 11:05am to 12:40pm
Morning General Session Continues
Grand Ballroom, Concourse Level
11:05AM - 11:30AM
Zeitgeist Presentation: Re-Emergence of Drug Delivery Facilitated by the Disruption Effects of GLP-1 Drugs and Nucleic Acid Modalities
Zeitgeist:
Anand Subramony, PhD, Vice President, Drug Delivery, Device, Connected Solutions & Innovation, Eli Lilly and Company
11:30AM - 11:45AM
High Drug Load Formulations for Small and Large Molecules
Speaker:
Christopher Worrall, PhD, VP, US Business Development, Nanoform
11:45AM - 12:25PM
Pharma Company Spotlights
Speakers:
Stephen Buckley, PhD, VP, Advanced Drug Delivery, Novo Nordisk
Christoph Marschall, PhD, Head of Laboratory, Boehringer Ingelheim
Christopher Rodricks, MBA, Senior Director, Strategic Partnerships, Pfizer Ignite, Business Innovation Office, Pfizer
Harshal Shah, MBA, Head of Device Strategy & Innovation, Global Device and Packaging Unit (GDPU), Sanofi
Jill Steinbach-Rankins, PhD, Senior Associate Director, Innovation Technology, Boehringer Ingelheim
12:25PM - 12:40PM
Feasibility Assessments: Partnering Early to Mitigate Combination Product Development Risks and Improve Speed to Market
Speakers:
Peter Skutnik, Business Director, Wearables, BD Medical-Pharmaceutical Systems
Showing Events in 1 Track from 12:40pm to 01:40pm
Luncheon & Partnering Meetings
12:40PM - 1:40PM
Luncheon & Partnering Meetings
Showing Events in 1 Track from 01:40pm to 06:30pm
The Annual PODD Drug Delivery Technology Presentations in Ten Tracks
1:40PM - 6:30PM
The Annual PODD Drug Delivery Technology Presentations in Ten Tracks
Showing Events in 5 Tracks from 01:45pm to 04:00pm
Track 1A: Injectable Formulations & Technologies
Grand Ballroom A, Concourse Level
Chaired by:
F. Javier Muñoz, PhD, MBA, Technology Evaluation Leader, F Hoffmann-La Roche
1:45PM - 2:00PM
SynBiosys ® LAI Microspheres and In Situ Forming Depots for Delivery of Peptides and Biologics
Speakers:
Rob Steendam, PhD, Chief Technology Officer, InnoCore Pharmaceuticals
2:00PM - 2:15PM
PharmaShell® Technology Enabling Long Acting GLP-1 Products
Speaker:
David Westberg, CEO, Nanexa
2:15PM - 2:30PM
Supplier Partner Proactivity to Support the Development of Reliable Combination Product Delivery Systems
Speaker:
Sylvain Stamper, R&D System Integration Leader, BD
2:30PM - 2:45PM
Chroniject Technology: A Solution to Long Acting Injectable Formulation and Scale-Up Challenges
Speakers:
Colin Spencer, Head of Technology Transfer, Project Manager, Oakwood Labs
2:45PM - 3:00PM
Dynamic Symbiosis of Drug Solubility, Microstructure and Polymer Chemistry in PLGA Microspheres
Speaker:
Andrew Clark, PhD, Director of Pharmaceutical Science, DigiM Solution
3:00PM - 3:15PM
Surf SnapShot™ Technology: An Injection in Seconds Instead of an Infusion in Hours
Speaker:
Bryan Mazlish, CEO, Surf Bio
3:15PM - 3:30PM
PURASORB®: Bioresorbable Polymers for Long-Acting Injectables: Past, Present, and Future
Speaker:
Morgan Fox, MSE, Senior Manager, Sales, Corbion
3:30PM - 3:45PM
BEPO® Technology : Flexible Design to Address Challenging Needs
Speaker:
Christophe Roberge, PhD, Partnering Director, MedinCell
3:45PM - 3:52PM
AI-Driven Automation for LAI Discovery and Scale-Up – A Case Study
Speaker:
Karthik Raman, PhD, CEO, Persist AI
3:52PM - 4:00PM
Oncolize: Treating Tumors from the Inside
Speaker:
Mike G.W. de Leeuw, Founder & CEO, OncoLize
Track 2A: Novel Devices: Self-Injectables, Wearables & Connected Devices
Grand Ballroom B, Concourse Level
Chaired by:
Kinsuk Shah, M.Sc and MBA, SR AD, Combination Product Steward, Boehringer Ingelheim
1:45PM - 2:00PM
Meet SHL Medical’s Elexy™: Versatile. Reusable. Connected
Speaker:
Vince Masciopinto, Customer Solutions Director, SHL Medical
2:00PM - 2:15PM
Case Study: Proving the Gas-Powered AltaVISC Significantly Expands Delivery Window for High Viscosity / High-Volume Drugs
Speaker:
Nelson Quintana, Director, Drug Delivery Programs, Altaviz
2:15PM - 2:30PM
Navigating Trade-offs in Re-usable Injector Design: Balancing Sustainability, Cost, and Patient Outcomes
Speaker:
Steve Gowers, Head of Drug Delivery & Digital Health, TTP
2:30PM - 2:45PM
Vertical Integration Strategies that Propel Drug Delivery Systems to Market
Speaker:
Greg Panebianco, Sr. Director of Engineering & Customer Success, Flex
2:45PM - 3:00PM
Device Design and Container Challenges in Complex Formulations
Speaker:
Uri Baruch, Vice President and General Manager, SMC Ltd
3:00PM - 3:15PM
Targeted Drug Delivery: a Journey to Precise, Repeatable and Personalized Drug Delivery
Speaker:
John Burke, Managing Consultant, Team Consulting
3:15PM - 3:30PM
Industry Partnering for Successful Combination Products
Speaker:
Philipp Richard, MBA, Account & Business Development Manager, Ypsomed
3:30PM - 3:45PM
Connected Health – Is the Near-Term Opportunity in Clinical Development?
Speaker:
Andrew Dundon, Director Drug Delivery Systems Strategy, Jabil Pharma Delivery Solutions
3:45PM - 4:00PM
Considerations for Building a Low-Risk, Highly Scalable Supply Chain for Drug-Device Combination Products
Speaker:
Bill Welch, Executive Director Market Development, PCI Pharma Services
Track 3A: Oral, Mucosal, Transdermal & Other Non-Injectable Technologies
Grand Ballroom D/E, Concourse Level
Chaired by:
Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals
1:45PM - 2:00PM
Exploring the Potential of Intranasal Delivery: The Next Era
Speaker:
Reenal Gandhi, Director, Business Development, Aptar Pharma
2:00PM - 2:15PM
Development and Pharmacoscintigraphic Analysis of Novel Dual-pulse Fixed Dose Combination Tablet
Speaker:
Darren Quinn, MChem, Head of Business Development, BDD Pharma
2:15PM - 2:30PM
Right from the Start: A Rapid Approach to Flexible and Scalable Drug Product
Speaker:
Jaspreet Arora, PhD, Director of Business Development, Serán Bioscience
2:30PM - 2:45PM
Solving the Insoluble: Disrupting Product Opportunities with Zerion’s Dispersome® Technology
Speaker:
Korbinian Löbmann, CSO & Co-Founder, Zerion Pharma A/S
2:45PM - 3:00PM
OzmoCAP®, a New Osmotic, Controlled Release Capsule
Speaker:
Kenneth Waterman, PhD, President, FreeThink Technologies, Inc.
3:00PM - 3:15PM
Sprinkle on Soft Food Formulations: An Easy-to-Swallow Dosage Format with Dose Flexibility
Speaker:
Srinivasan Shanmugam, PhD, Executive Director, Pharmaceutical Sciences, Adare Pharma Solutions
3:15PM - 3:30PM
Gastro-Retentive Drug Delivery Via Novel 3D Printed Tablets
Speakers:
Timothy Tracy, PhD, Senior Advisor, Triastek
3:30PM - 3:45PM
Solving Drug Delivery Challenges with Ingestible Drug-Device Combinations
Speaker:
Adi Mohanty, MBA, CEO, Biora Therapeutics, Inc.
3:45PM - 3:52PM
Revolutionizing Antiviral Treatments: Phase II Ready Orally Available Nanomedicines that Can Deliver Difficult APIs and Improve PK
Speaker:
Anil Diwan, PhD, President & Executive Chairman, Nanoviricides
3:52PM - 4:00PM
A Multi-Day Gastroretentive Drug Delivery Platform for Sustained Release of Small Molecules and Peptides
Speaker:
Camilla Easter, BVMedSci BVM BVS MRCVS, CEO, Oxford Medical Products
Track 4A: Cell & Gene Delivery
Marina Ballroom I/II, Lobby Level
Chaired by:
Alireza Nomani, PhD, PharmD, Principal Scientist, Regeneron Pharmaceuticals
1:45PM - 2:00PM
Navigating the Last Mile: Best Practices for Successful Delivery Device Development for Advanced Therapies
Speaker:
Nathan Blazei, Senior Director, Strategic Solutions, Kymanox
2:00PM - 2:15PM
COATSOME® SS Series:Highly Versatile Ionizable Lipid as Vital Component of Lipid Nanoparticle for Gene Therapy and Vaccine Application
Speaker:
Kasumi Ito, Research scientist, NOF CORPORATION
2:15PM - 2:30PM
Precision Drug Delivery: Customized Cell Encapsulation, Hydrogels and Microbeads to Target Therapeutics Exactly Where They’re Needed
Speaker:
Dr. Stella Vnook, CEO, Likarda
2:30PM - 2:45PM
Delivering on the Promise of Genetic Medicines: Safe and Effective In Vivo Delivery of Nucleic Acids with the Fusogenix PLV Platform
Speaker:
John Lewis, PhD, CEO, Entos Pharmaceuticals
2:45PM - 3:00PM
SAIL Biomedicines – Generating Tomorrow’s Medicines Today
Speaker:
Kerry Benenato, PhD, Chief Platform Officer, Sail Biomedicines
3:00PM - 3:15PM
SORT LNP Platform for Hepatic and Extrahepatic Delivery
Speaker:
Ariel Kantor, PhD, SVP, Head of Business & Corporate Development, ReCode
3:15PM - 3:30PM
Novel Ultrasound Guided Non-Viral Gene Therapy Platform Allows Targeting of Almost any Organ
Speaker:
Shawn Fu, MD, Vice President of CorpDev and Head of Strategy, SonoThera
3:30PM - 3:45PM
Design and Optimization of a Peptoid-Based Platform for Therapeutic mRNA Delivery
Speaker:
Colin McKinlay, PhD, Senior Director, Chemistry and Delivery Technologies, Nutcracker
3:45PM - 3:52PM
A Simple, Safe, Affordable and Scalable Intracellular Delivery Platform for “Naked” RNA/DNA Vaccines and Therapeutics
Speaker:
Gaurav Byagathvalli, CEO, Piezo
3:52PM - 4:00PM
Making Oligonucleotides Better Medicines with Bottlebrush Polymers
Speaker:
Carl LeBel, PhD, CEO, pacDNA
Track 5A: Excipient Innovation
Marina Ballroom III/IV, Lobby Level
Chaired by:
Stephen Spagnol, PhD, Director, Business Development & Licensing, Merck
1:45PM - 2:00PM
Targeted Delivery of Microbiome: A Case Study on Development of Functional Coated Capsules Leading to Clinical Trial
Speaker:
Mohammed Irfan Syed, PhD, Associate Director, Formulation & Application Services, Evonik
2:00PM - 2:15PM
mPredict™ Co-crystal Prediction Service: An Introduction to faster co-crystal screening
Speakers:
Mitali Bhagwat, M.Pharm, Strategic Product manager, MilliporeSigma
2:15PM - 2:30PM
Utilizing Poly(2-oxazoline) Triblock Copolymers to Increase Solubility, Bioavailability and Anti-tumor Activity of Poorly Soluble Drugs In Vivo
Speaker:
Bruce Frank, PhD, President and Chief Scientific Officer, DelAQUA Pharmaceuticals, Inc.
2:30PM - 2:45PM
Does the Purity of Dimethyl Sulfoxide Affect Cell viability?
Speaker:
Nigel Langley, PhD, MBA, FRSC, Global Technical Director Life Sciences, Gaylord Chemical
2:45PM - 3:00PM
Phospholipid Excipients, Existing Usages and Key Advantages
Speaker:
Alexander Aydt, PhD, Senior Manager, Lipoid LLC
3:00PM - 3:15PM
Hydralese®: A Tunable Polymer Platform for Long-Acting Drug Delivery
Speaker:
Manasi Baker, PhD, Senior Scientist, Secant Group
3:15PM - 3:30PM
API Carrier: Hyaluronic Acid Nanogel (Sonanos™) for Sustained Release and Solubility Enhancement
Speaker:
Yoshiyuki Nakagawa, PhD, Assistant Manager, Asahi Kasei Corporation
3:30PM - 3:37PM
Dramatic Oncolytic Virus Transduction Through Targeted and Protected Intravenous Administration
Speaker:
Clay Larsen, President and CEO, Vesselon, Inc.
3:37PM - 3:45PM
Biotts’ MTC-Y Technology: Revolutionizing Diabetology with Needle-Free, Non-Invasive Transdermal Insulin Delivery
Speaker:
Pawel Biernat, PhD, Co-founder and Patent Co-author, Biotts
Showing Events in 1 Track from 04:00pm to 04:25pm
Networking Break
4:00PM - 4:25PM
25-Minute Ice Cream and Networking Break
Showing Events in 5 Tracks from 04:30pm to 06:30pm
Track 1B: Injectable Formulations & Technologies
Grand Ballroom A, Concourse Level
Chaired by:
Srini Sridharan, PhD, Executive Director, Drug Delivery & Product Integration, Bristol-Myers Squibb
4:30PM - 4:45PM
Challenge Accepted: TheraPEA Innovation for Long Acting Formulations of Biologics
Speaker:
George Mihov, PhD, Principal Scientist - Drug Delivery Solutions, dsm-firmenich
4:45PM - 5:00PM
New Containment Solutions to Mitigate Risk for Gene Therapies
Speaker:
Vidya Murthy, PhD, Director, Scientific Communication, Advanced Therapies, West Pharmaceutical Services
5:00PM - 5:15PM
Revolutionizing Drug & Vaccine Delivery with Blow Fill Seal
Speaker:
Joseph (Joe) Wojcik, MBA, PMP, Senior Director, Pharmaceutical Development Services, ApiJect
5:15PM - 5:30PM
Avoid Injectables Pitfalls: 5 Early Considerations to Shorten Timelines and Reduce Costs Throughout Your Program
Speaker:
Ryan Swanson, PhD, Director of Process Development, Lifecore Biomedical, LLC
5:30PM - 5:45PM
Innovative Dual Chamber Blow Fill Seal (BFS) Injection System Development: A Collaborative Case Study by ApiJect and PSN Labs
Speakers:
Mark Burchnall, Engineering Director, PSN Labs
Molly Weaver, PhD, Chief Operating Officer, ApiJect
5:45PM - 6:00PM
The Nanoprimer: A Significant Opportunity to Boost the Efficacy of Nanomedicine
Speaker:
Matthieu Germain, Dr, Senior Director, Head of Curadigm Platform, Nanobiotix
6:00PM - 6:15PM
MAGiGSPHERE, High-Drug Loaded Microspheres for Long-Acting Injectables
Speaker:
Heeyong Lee, PhD, CEO, G2GBio
6:15PM - 6:22PM
Ultrasound-Mediated Drug Delivery for Enhanced Cancer Therapy and Tumor Microenvironment Modulation
Speaker:
Chung-Hsin Wang, PhD, Founder, Trust Bio-sonics Inc.
6:22PM - 6:30PM
Early Clinical Efficacy Results of SonoTran Presentation in mCRC Patients: A Game-Changing Ultrasound-Triggered Drug Delivery Solution
Speaker:
Jérôme Marzinski, MBA, CEO, OxSonics
Track 2B: Novel Device Technologies
Grand Ballroom B, Concourse Level
Chaired by:
Dominick DeGrazio, Early Project Engineering Lead, Early Engagement and Deviceability, GSK
4:30PM - 4:45PM
Innovating for Pediatric Access to Address Unmet and Emerging Drug Delivery Needs in Applications Involving Variable Dosing
Speaker:
Gautam Shetty, PhD, Founder, CEO, Congruence Medical
4:45PM - 5:00PM
3 Essential Rules of Mechanical Design in a Connected World
Speaker:
Jon Powell, Head of Manufacturing, Cambridge Design Partnership
Linda Tharby, President and CEO, Koru Medical
5:00PM - 5:15PM
The Emerging Role of Nanoparticle Delivery Platform Technologies in the Translation of Genetic Medicines
Speaker:
Anthony Duong, PhD, Lead Drug Delivery Scientist, Battelle
5:15PM - 5:30PM
The Reality of the Large Volume Subcutaneous Device Landscape: How to Stick the Landing of Commercialization
Speaker:
Adam Edelhauser, Director of R&D, KORU Medical Systems
5:30PM - 5:45PM
Breakthroughs in Micro Molding for Drug Delivery – Unlocking New Frontiers
Speaker:
Brent Hahn, MBA, SVP, Isometric Micro Molding
5:45PM - 6:00PM
Ampoule Filled Syringe: The PFS Alternative that Delivers Superior Shelf Life While Reducing Years of Development and Manufacturing Time
Speaker:
Eric Sugalski, Founder & CEO, Archimedic
6:00PM - 6:15PM
Joint Exploration Project: Pre-Filled Syringe Enabling Intradermal Delivery
Speaker:
Uli Kuchenbrod, MBA, Director Product Development & Design, Vetter Pharma-Fertigung GmbH & Co KG
6:15PM - 6:22PM
Software Modulated Wearable Subcutaneous Delivery for Patient Acceptance and Time/Cost to Market
Speaker:
David Johnston, Chief Product Officer, Torramics
6:22PM - 6:30PM
A Novel Subcutaneous & Intra-Muscular Closed System Transfer Device
Speaker:
William Wijnberg, COO, Zephyrus Innovations
Track 3B: Novel Injectable and Non-Injectable Technologies
Grand Ballroom D/E, Concourse Level
Chaired by:
Abhijeet Maurya, PhD, Principal Scientist, Amgen
4:30PM - 4:45PM
Disaccharides: Simple Raw Materials or a Hidden Weakness in the Biopharmaceutical Supply Chain?
Speaker:
Ross Blezard, Global technical lead: Biopharma and Inhalation, DFE Pharma
4:45PM - 5:00PM
Creating Next Generation Therapies with Drug-Eluting Implants
Speaker:
Tom Quinci, Global Leader for External Innovation and Partnerships, Celanese
5:00PM - 5:15PM
Nanomedicine Development and Manufacturing with DELOS Nanovesicle Technology
Speaker:
Alba Cordoba, PhD, Tech Transfer & Business Development Director, Nanomol Technologies
5:15PM - 5:30PM
Fill and Finish for Reconstituted Product Devices
Speaker:
Joan Melé, Chief Commercial Officer, Dara
5:30PM - 5:45PM
Spray Drying to Overcome Cold Storage of RNA-Loaded Lipid Nanoparticles
Speaker:
Mark Kastantin, PhD, VP of Manufacturing Technology, Serán Bioscience
5:45PM - 6:00PM
Eliminating silos in the Drug Delivery Value Chain: A Case Study From Grand River Aseptic Manufacturing and LTS Lohmann Device Technologies
Speaker:
Mary Lou Glotzbach, Business Development Executive, Grand River Aseptic Manufacturing
Greg Moakes, PhD, MBA, Executive Vice President, Business Development, Sorrel Platform, LTS Lohmann Therapie-Systeme AG, LTS Device Technologies
6:00PM - 6:15PM
Cutting-Edge Liposomal Nano-Drug Delivery: Clinical Breakthroughs in Oncology and Neurology
Speaker:
Stéfan Halbherr, PhD, CEO / Country Manager, InnoMedica Switzerland AG
6:15PM - 6:22PM
Unlocking Vaginal Drug Delivery Opportunities with Callavid®
Speaker:
Andrew Lewis, PhD, Principal Scientist, Calla Lily Clinical Care
6:22PM - 6:30PM
Enabling Transdermal Delivery of Large Molecules and Combination Therapies
Speaker:
Jake Lombardo, CEO & Co-founder, Anodyne
Track 4B: Cell, Gene & Novel Biologics Delivery
Marina Ballroom I/II, Lobby Level
Chaired by:
Samantha Sarett, PhD, Senior Director, Nanomedicines, Eli Lilly and Company
4:30PM - 4:45PM
​​Non-Lipid Polymer-Based Nanoparticles - Unlocking Gene Therapy Delivery Potential
Speaker:
Shira Orr, PhD, CEO, Envoya
4:45PM - 5:00PM
Size Controllable LNP Fabrication Plays a Crucial Role in Advancing LNPs Towards the Clinic
Speaker:
Matt Freeman, PhD, Senior Scientist, Phosphorex
5:00PM - 5:15PM
The Sustained Release of Biologics, Large and Small Molecules with Novel Photo Crosslinked Biodegradable Technologies
Speaker:
Patrick Ruane, PhD, Chief Operating Officer, Re-Vana Therapeutics
5:15PM - 5:30PM
Crossing Barriers: Pioneering Intracellular Delivery in Biologic Therapies
Speaker:
Tal Sines, PhD, VP of Business Development, Biond Biologics
5:30PM - 5:45PM
yEVs for delivery of Proteins, Nucleic Acids and Small-Molecule Drugs
Speakers:
Bruce McCormick, CEO, Mercury Bio
5:45PM - 6:00PM
MINC: A Revolutionary Brain Delivery Platform for Biologics
Speaker:
Pauline Lau, PhD, CEO, Suntec Medical, Inc.
6:00PM - 6:15PM
Lipid Nanoparticles – Carriers for Biologics and Nucleic Acids Delivery
Speaker:
Shaukat Ali, PhD, Senior Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
6:15PM - 6:22PM
Turning Implantable Devices into Therapeutic Treatments: Ushering in the Next Evolution in Targeted Therapies
Speaker:
Luis Alvarez, PhD, Founder & CEO, Theradaptive
6:22PM - 6:30PM
Enabling Gene-Length DNA Insertions with Single-Stranded DNA Templates Adaptable to Non-Viral Delivery Modalities
Speaker:
Floris Engelhardt, PhD, CEO/CSO, Kano Therapeutics
Track 5B: Self-Injection Devices, Syringes, Primary Container & Packaging Solutions
Marina Ballroom III/IV, Lobby Level
Chaired by:
Theresa Scheuble, Head, Enterprise Design & Innovation, Johnson and Johnson
4:30PM - 4:45PM
Solutions for Emerging Challenges in Injectable Drug Delivery
Speaker:
Laxman Halleppanavar, Head of Portfolio Strategy and Management, Credence MedSystems, Inc.
4:45PM - 5:00PM
Titration Dosing with Auto-Injectors: The Critical Importance of Device Selection
Speaker:
Rob Schulz, RAC, Senior Vice President, Suttons Creek
5:00PM - 5:15PM
Integrating Primary container solutions with CDMO capabilities for Biotech parenteral drugs
Speaker:
Michele Guasti, Global Product Manager at the Pharmaceutical Solutions Division, Terumo
5:15PM - 5:30PM
Digital Drug Delivery
Speaker:
Patrick Anquetil, PhD, MBA, CEO, Portal Instruments
5:30PM - 5:45PM
Meeting GLP-1 Market Needs: Your One-Stop Solution for Comprehensive Auto-Injector and Pen Injector Systems
Speakers:
Tommaso Borghi, PhD, Director of Product Development of Drug Delivery Systems, Stevanato Group
5:45PM - 6:00PM
Vaccine Wastage Reduction With Newly Developed Blow/Fill/Seal Packaging
Speaker:
Tim Kram, Managing Director, Rommelag USA
6:00PM - 6:15PM
Sterile Product Introduction and Tech Transfers in a Crowded Market
Speaker:
Kimberly Brown, Director, Client Portfolio & Relationship Management, Kindeva
6:15PM - 6:22PM
Dual Chamber, Wearable, Subcutaneous Delivery Device
Speaker:
Kevin Schmid, Chief Operating Officer, Modular Medical
6:22PM - 6:30PM
Pharma Latch: Intradermal is Now a Realistic & Exciting Route of Administration
Speakers:
Adam Rock, Strategic Partnerships and Commercialisation Manager, Pharma Latch
Showing Events in 1 Track from 06:30pm to 07:30pm
PODD Networking Reception & Partnering Meetings
6:30PM - 7:30PM
PODD Networking Reception & Partnering Meetings
Hosted By:
Showing Events in 1 Track from 07:30pm to 07:35pm
Day One Concludes
7:30PM - 7:35PM
Day One Concludes
Previous
Day 1
Monday, October 28, 2024

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.